RPL35AA Antibody

What is RPL35AA and what cellular functions does it serve?

RPL35AA is a member of the L35AE family of ribosomal proteins and serves as a component of the 60S ribosomal subunit in eukaryotes. In plant species such as Arabidopsis thaliana, RPL35AA plays critical roles in protein synthesis machinery. While structurally similar to mammalian RPL35A, the plant RPL35AA has specific functions in ribosome assembly and translation . Functionally, ribosomal proteins like RPL35AA are located in the cytoplasm and participate in the translation process by interacting with transfer RNAs. Based on studies of homologous proteins, RPL35AA likely binds to both initiator and elongator tRNAs, positioning it at the P site or both P and A sites of the ribosome .

What applications is the RPL35AA antibody validated for?

The RPL35AA antibody (e.g., CSB-PA888755XA01DOA) has been specifically validated for ELISA and Western Blot applications in plant research, particularly with Arabidopsis thaliana samples . When designing experiments, researchers should note that this antibody was raised against recombinant Arabidopsis thaliana RPL35AA protein in rabbits, making it most suitable for plant-based research systems. Unlike other ribosomal protein antibodies that show cross-reactivity with human or rodent samples, the RPL35AA antibody discussed here is optimized for plant research applications .

What are the optimal storage and handling conditions for RPL35AA antibodies?

For maximum stability and activity retention, RPL35AA antibodies should be stored at -20°C or -80°C immediately upon receipt . The antibody is typically provided in liquid form with a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . Researchers should avoid repeated freeze-thaw cycles as these can degrade antibody performance. For working solutions, aliquoting the stock antibody and maintaining cold chain management during experimental procedures is recommended to preserve specificity and sensitivity.

How should I optimize Western blot protocols for RPL35AA detection?

When optimizing Western blot protocols for RPL35AA detection in plant samples, researchers should consider the following methodological approach:

• Sample preparation: Extract total protein from plant tissues using appropriate lysis buffers that preserve ribosomal protein integrity

• Protein separation: Run 15-18% SDS-PAGE gels as RPL35AA has a relatively low molecular weight (similar to the 15 kDa observed for related RPL35)

• Transfer conditions: Use PVDF membranes with optimization for small proteins (higher methanol percentage in transfer buffer)

• Blocking: 5% non-fat dry milk or BSA in TBST for 1-2 hours at room temperature

• Primary antibody incubation: Dilute RPL35AA antibody following manufacturer recommendations, typically in the range of 1:200-1:1000 , and incubate overnight at 4°C

• Detection: Use appropriate secondary antibodies conjugated to HRP or fluorescent tags followed by imaging

This methodological approach ensures optimal detection while minimizing background and non-specific binding.

How can I determine RPL35AA expression levels across different developmental stages in plants?

To quantify RPL35AA expression across developmental stages in plants, a comprehensive approach combining multiple techniques yields the most reliable results:

• Quantitative RT-PCR analysis: Design primers specific to RPL35AA transcripts, similar to the approach used for related ribosomal proteins. For example, adapting primer design strategies from related ribosomal proteins: forward primer 5′-GAAGGTGTTTACGCCCGAGAT-3′ and reverse primer 5′-CGAGTTACTTTTCCCCAGATGAC-3′ . Ensure validation of primer specificity for your target sequence.

• Western blot quantification: Use the RPL35AA antibody in Western blots with protein extracts from different developmental stages, normalizing to appropriate housekeeping proteins.

• Immunohistochemistry: Apply immunohistochemistry techniques with optimized antigen retrieval (based on protocols for related ribosomal proteins, consider TE buffer pH 9.0 or citrate buffer pH 6.0) to visualize spatial distribution across different tissues.

• Data integration: Compile expression data into developmental expression profiles, correlating transcript and protein levels to identify potential post-transcriptional regulation.

This multi-technique approach addresses potential discrepancies between mRNA and protein expression levels that might occur due to translational regulation or protein stability differences across developmental stages.

How can I investigate potential non-canonical functions of RPL35AA beyond its role in ribosomes?

Recent research on ribosomal proteins has revealed that many perform functions beyond their canonical roles in translation. To investigate potential non-canonical functions of RPL35AA:

• Protein-protein interaction studies:

  • Perform co-immunoprecipitation experiments using the RPL35AA antibody followed by mass spectrometry to identify novel interaction partners

  • Validate interactions with candidate proteins using techniques such as proximity ligation assays or FRET

  • Map interaction domains through truncation mutants

• Subcellular localization analysis:

  • Conduct immunofluorescence studies with the RPL35AA antibody to identify potential non-ribosomal localizations

  • Create fluorescent protein fusions and observe localization under various stress conditions

  • Perform biochemical fractionation to identify RPL35AA in unexpected cellular compartments

• Functional studies:

  • Utilize CRISPR/Cas9 genome editing to create RPL35AA mutants and assess phenotypes beyond translation defects

  • Perform rescue experiments with mutant variants to separate ribosomal from extra-ribosomal functions

  • Analyze stress responses to determine potential roles in signaling pathways

This systematic approach allows researchers to uncover novel functions of RPL35AA that may contribute to plant development or stress responses beyond protein synthesis.

What are the methodological considerations when studying RPL35AA involvement in plant stress responses?

When investigating RPL35AA's role in plant stress responses, researchers should implement rigorous methodological approaches that account for the complex nature of ribosomal protein regulation:

• Experimental design considerations:

  • Include appropriate time-course analyses (early, intermediate, and late responses)

  • Apply gradients of stress intensity rather than single-point measurements

  • Control for circadian effects on gene expression

  • Use multiple ecotypes/accessions to account for genetic variation

• Expression analysis methodology:

  • Implement RT-qPCR with multiple reference genes validated for stability under the specific stress conditions

  • Conduct western blot quantification controlling for total protein loading (Ponceau staining) rather than single housekeeping proteins that may change under stress

  • Consider polysome profiling to assess translational regulation

• Functional validation approaches:

  • Generate both knockdown and overexpression lines

  • Design rescue experiments with wild-type and mutant variants

  • Apply transcriptome and translatome analyses to distinguish direct from indirect effects

This comprehensive approach enables researchers to differentiate between RPL35AA's direct involvement in stress responses versus secondary effects due to altered translation capacity.

How can I resolve discrepancies between antibody-based detection methods for RPL35AA?

Researchers occasionally encounter contradictory results when using antibody-based techniques to study RPL35AA. To systematically resolve these discrepancies:

• Antibody validation strategy:

  • Perform side-by-side comparison of different antibody lots using the same samples

  • Include positive controls (recombinant protein) and negative controls (knockout/knockdown samples)

  • Test for cross-reactivity with related ribosomal proteins (e.g., RPL35)

  • Validate specificity through pre-absorption tests and immunoprecipitation-mass spectrometry

• Method-specific considerations:

  • For Western blots: Compare different protein extraction methods, particularly considering detergent composition that may affect ribosome integrity

  • For immunohistochemistry: Evaluate multiple antigen retrieval methods, as suggested for related ribosomal proteins (TE buffer pH 9.0 vs. citrate buffer pH 6.0)

  • For ELISA: Assess different blocking agents to minimize background

• Data interpretation approach:

  • Triangulate results using orthogonal methods (e.g., RNA-seq, proteomics)

  • Consider post-translational modifications that might affect epitope recognition

  • Evaluate antibody performance under different experimental conditions (native vs. denaturing)

This systematic troubleshooting workflow helps researchers identify sources of variability and establish reliable protocols for consistent RPL35AA detection.

What controls should I include when using RPL35AA antibodies in immunolocalization studies?

Robust immunolocalization studies of RPL35AA require comprehensive controls to ensure specificity and reliability:

• Essential controls:

  • Positive control: Tissues known to express RPL35AA at high levels

  • Negative control: RPL35AA knockdown/knockout tissues when available

  • Technical negative controls: Primary antibody omission, isotype controls, and pre-immune serum

  • Absorption control: Pre-incubation of antibody with recombinant RPL35AA antigen

• Validation approaches:

  • Confirm localization pattern using complementary techniques (e.g., fluorescent protein fusion)

  • Test multiple fixation protocols to ensure epitope preservation

  • Compare results using antibodies raised against different epitopes of RPL35AA

• Co-localization strategy:

  • Include markers for ribosomal structures (nucleolus, cytoplasmic ribosomes)

  • Use subcellular markers to confirm expected localization patterns

  • Perform co-staining with antibodies against known interaction partners

This comprehensive control strategy ensures that observed immunolocalization patterns accurately reflect the true distribution of RPL35AA protein in plant tissues.

How should I approach comparative studies of RPL35AA across different plant species?

When conducting comparative studies of RPL35AA across plant species, researchers should implement a systematic approach that accounts for both evolutionary conservation and species-specific variations:

• Sequence analysis workflow:

  • Perform sequence alignment and phylogenetic analysis of RPL35AA across target species

  • Identify conserved domains and species-specific variations

  • Map epitope regions recognized by available antibodies to assess potential cross-reactivity

• Cross-reactivity testing protocol:

  • Validate antibody recognition using recombinant proteins from each species when possible

  • Perform Western blot analysis with appropriate positive controls

  • Optimize immunoprecipitation conditions for each species separately

• Expression analysis strategy:

  • Design primers in conserved regions for RT-qPCR studies

  • Normalize expression data using evolutionarily stable reference genes

  • Account for different tissue compositions when comparing homologous organs

• Functional comparison approach:

  • Perform complementation studies using heterologous expression systems

  • Evaluate conservation of protein-protein interactions across species

  • Assess response to evolutionary conserved stresses (e.g., heat, drought)

How do I address high background signal when using RPL35AA antibodies?

High background is a common challenge when working with antibodies against abundant proteins like RPL35AA. To systematically reduce background and improve signal-to-noise ratio:

• Optimization strategy for Western blots:

  • Increase blocking stringency (5% BSA or 5% milk in TBST for 2 hours)

  • Test different antibody dilutions, starting from the higher end of recommended ranges (1:1000)

  • Increase washing duration and volume between antibody incubations

  • Consider using specialized blocking reagents designed for plant samples

  • Add 0.05-0.1% SDS to antibody dilution buffer to reduce non-specific binding

• Immunohistochemistry and immunofluorescence optimization:

  • Test different fixation protocols to optimize epitope preservation while minimizing autofluorescence

  • Implement tissue-specific antigen retrieval methods similar to those used for related ribosomal proteins

  • Include detergent (0.1-0.3% Triton X-100) during antibody incubation

  • Use longer wash steps (6 x 10 minutes) between incubations

  • Consider photobleaching steps for plant tissues with high autofluorescence

• ELISA background reduction:

  • Optimize coating buffer composition and concentration

  • Implement additional blocking steps with irrelevant proteins

  • Test different detection systems with potentially lower background

These methodological adjustments should be implemented systematically, changing one variable at a time to identify the optimal conditions for your specific experimental system.

What approaches can resolve contradictory findings between transcript and protein levels of RPL35AA?

Discrepancies between RPL35AA transcript and protein levels are not uncommon due to complex post-transcriptional and post-translational regulation. To resolve such contradictions:

• Temporal analysis strategy:

  • Perform time-course experiments to account for delays between transcription and translation

  • Include multiple time points after treatment or developmental transitions

  • Analyze samples at consistent times of day to control for circadian effects

• Methodological validation approach:

  • Verify RNA integrity and quality before RT-qPCR analysis

  • Validate antibody specificity using recombinant protein and knockout/knockdown lines

  • Employ multiple protein extraction methods to ensure complete recovery

  • Consider polysome profiling to assess translational efficiency

• Regulatory mechanism investigation:

  • Analyze mRNA stability using actinomycin D treatment

  • Assess protein turnover rates with cycloheximide chase experiments

  • Investigate potential non-coding RNAs that might regulate RPL35AA expression

  • Examine post-translational modifications that could affect protein stability

• Data integration approach:

  • Construct mathematical models incorporating transcription, translation, and degradation rates

  • Apply statistical methods appropriate for time-series data

  • Consider systems biology approaches to place findings in broader regulatory networks

This comprehensive strategy helps researchers identify the biological basis for observed discrepancies rather than dismissing them as technical artifacts.

What emerging techniques could enhance the study of RPL35AA function in plant development?

Several cutting-edge methodologies are poised to transform our understanding of RPL35AA's role in plant development:

• Innovative genetic approaches:

  • CRISPR base editing for precise mutation introduction without disrupting gene expression

  • Tissue-specific and inducible CRISPR systems for temporal control of RPL35AA disruption

  • Single-cell transcriptomics to map RPL35AA expression in rare cell populations

  • Ribosome profiling to assess translational impact of RPL35AA perturbation

• Advanced protein analysis techniques:

  • Proximity labeling (BioID, TurboID) to identify context-specific interaction partners

  • In vivo structural studies using cryo-electron tomography

  • Single-molecule imaging to track RPL35AA dynamics in living cells

  • Antibody-free detection methods such as quantitative targeted proteomics

• Systems integration approaches:

  • Multi-omics data integration frameworks incorporating transcriptomics, proteomics, and metabolomics

  • Network analysis to position RPL35AA within developmental regulatory circuits

  • Comparative studies across diverse plant species to identify conserved functions

These emerging techniques will enable researchers to move beyond correlative observations toward mechanistic understanding of RPL35AA function throughout plant development.